Ruxolitinib Oral Tablet [Jakafi] Clinical Trials

2 actively recruiting trials across 2 locations

Also known as: Ruxolitinib, Jakafi, Ruxolitinib, Jakavi

Filter by location:

Alhambra, California1 trial

A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients

Global Oncology, Inc.

Phase 1

West Hollywood, California1 trial

Pilot Study Using Changes in Serum BCMA to Determine Disease Progression in Multiple Myeloma

Berenson Cancer Center

Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.